drugset / Trial / NCT02286531

Evaluation de O-(2-[18F]-Fluoroethyl)-L-Tyrosine, a New Tracer PET, in the Diagnosis of Low Grade Glioma

NCT02286531 ↗

Completed 93 enrolled University Hospital, Toulouse
NaSingle-groupOpen-labelDiagnostic

Summary

Determine the overall discriminatory ability of FET PET in the diagnosis of glioma grade II (referring to the current diagnostic gold standard represented by the histopathology exam of a tumor sample).

Timeline

Start
2010-06
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject O-(2[18F]FLUOROETHYL)-L-TYROSINE Unknown 3.7 mbq/kg Intravenous

Indications